Drug Discovery & Trials

9+ min ago   (266+ words) At the Oct. 7-9 event, TherapiAI met with at least 113 companies from seven countries, including Japan, Taiwan, the United States, South Korea, Germany, France and Switzerland. Sixteen biopharmaceutical CDMOs said they want to trial the platform or collaborate on Pharma 4.0 initiatives,…...

6+ hour, 55+ min ago   (342+ words) Recently, the term "physics" has appeared more and more frequently in the narrative context of AI4S and the pharmaceutical industry. Although the industry has not yet reached a consensus on what physical AI in the pharmaceutical industry exactly is, it seems…...

1+ hour, 47+ min ago   (367+ words) Engineering.com The collaboration targets scalable OEE monitoring, continued process verification and performance management across regulated manufacturing sites. Seeq announced it is collaborating with Cognizant, an AI Builder and technology services provider, to help life sciences and pharmaceutical manufacturers move…...

13+ hour, 31+ min ago   (451+ words) www.aap.com.au GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation Inaugural competition will connect emerging AI life sciences platforms with validation expertise, investors, and ecosystem partners during JPM Week PISCATAWAY, N.J. and SANTA CLARA, Calif.,…...

9+ hour, 3+ min ago   (604+ words) The gene-editing space has a new playbook aimed at radically reducing the work needed to bring these therapies to the clinic. “If we can leverage the platform and make the cost of the incremental effort to treat a mutation very…...

4+ hour, 2+ min ago   (624+ words) By RHEA MAKKUNI | October 9, 2026 COURTESY OF JONATHAN OUYANG Pictured here is the UPET team: Alisa Bryantseva, Anjali Vinodh, Brennan McGrann, Tanay Sanghvi, Yash Bhargava and Vanessa Zhang. As complicated as it may sound, protein engineering can seem like a field…...

3+ hour, 48+ min ago   (60+ words) A new review argues that insulin receptor signaling is a programmable, context-dependent network that engineered mimetics can selectively retune across diabetes, cancer, PCOS, and Alzheimer disease. Subject of Research: Non-canonical insulin receptor signaling and the design of insulin mimetics News…...

14+ hour, 13+ min ago   (421+ words) The articles in this eBook examine key trends driving this transformation, from AI-enabled discovery and experimental validation to advanced cell, gene, and biologic platforms, and explore how the next generation of therapies will move from concept to clinic. The post…...

10+ hour, 39+ min ago   (151+ words) Baker is a 2024 Nobel Laureate in Chemistry and a Howard Hughes Medical Institute investigator. Proteins are essential for all life. They interact at the atomic level to build everything we see in nature. The ability to accurately predict their structures…...

7+ hour, 12+ min ago   (824+ words) Bioengineer.org Artificial intelligence has become remarkably good at dreaming up proteins that stick to chosen targets, but a striking question has lingered behind the field's headline successes: does a protein that binds on a computer actually work inside a…...